BE AWARE several states, including Washington, have recently experienced local measles activity. Since the beginning of 2024 there have been nine measles cases reported in Washington state, including a cluster of eight cases in Clark and Wahkiakum Counties in January and a travel-associated case with multiple public exposures reported on February 21 in Spokane County. Nationwide, 36 measles cases … Health Advisory: Update on measles activity
Click here to access week 7 of the Kitsap Respiratory Illness Report. In week the week ending on Feb. 17, local indicators for influenza remained elevated. Indicators for COVID-19 and respiratory syncytial virus (RSV) continued to decline but remained slightly above what we’d expect to see outside of respiratory season. 1.4% of emergency department (ED) visits … Kitsap Respiratory Illness Report: Feb. 11 to Feb. 17
Click here to access week 6 of the Kitsap Respiratory Illness Report. In week ending Feb. 10, local indicators for COVID-19, influenza and RSV remained elevated. Influenza indicators rebounded following decreases the previous week. 2.4% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to influenza, and fewer than 10 visits were attributable … Kitsap Respiratory Illness Report: Feb. 4 to Feb. 10
Click here to access week 5 of the Kitsap Respiratory Illness Report. In week ending on Feb. 3, local indicators for COVID-19, influenza and RSV were elevated. Indicators for influenza and RSV are declining, but remain above local baselines. 1.9% of emergency department (ED) visits were attributable to COVID-19, and fewer than 10 visits were attributable … Kitsap Respiratory Illness Report: Jan. 28 to Feb. 3
Click here to access week 4 of the Kitsap Respiratory Illness Report. In week ending Jan. 27, local indicators for influenza remained high, and indicators for COVID-19 remained elevated. Indicators for RSV continued to decline, but are still above local baselines. 1.9% of emergency department (ED) visits were attributable to COVID-19, 1.1% were attributable to influenza, … Kitsap Respiratory Illness Report: Jan. 21 to Jan. 27
Click here to access week 3 of the Kitsap Respiratory Illness Report. In week ending on Jan. 20, local indicators for influenza and RSV remained high, but were declining for the second consecutive week. COVID-19 remained elevated. 2.5% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to RSV, and fewer than 10 … Kitsap Respiratory Illness Report: Jan. 14 to Jan. 20
Click here to access week 2 of the Kitsap Respiratory Illness Report. In the week ending Jan. 13, local indicators for influenza and RSV remained high, and COVID-19 remained elevated. Statewide, RSV activity appears to be declining. 2.8% of emergency department (ED) visits were attributable to COVID-19, 1.3% were attributable to influenza, and 1.1% were attributable to … Kitsap Respiratory Illness Report: Jan. 7 to Jan. 13
Click here to access week 1 of the Kitsap Respiratory Illness Report. In the week ending Jan. 6, local indicators for influenza and RSV remained high, but RSV activity appears to be dropping. COVID-19 remains elevated. 2.3% of emergency department (ED) visits were attributable to COVID-19, 1.3% were attributable to influenza, and 1.1% were attributable to … Kitsap Respiratory Illness Report: Dec. 31 to Jan. 6
Click here to access week 52 of the Kitsap Respiratory Illness Report. In week ending Dec. 30, indicators for all three monitored respiratory viruses (COVID-19, influenza and RSV) went up, showing increasing circulation in Kitsap County. RSV and influenza indicators are currently high, and COVID-19 indicators are elevated. 2.2% of emergency department (ED) visits were attributable … Kitsap Respiratory Illness Report: Dec. 24 to Dec. 30
ACTIONS REQUESTED BE AWARE the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Agency (DEA) announced the elimination of the requirement for prescribers to have a DATA 2000 (X) waiver to prescribe buprenorphine. BE AWARE of training requirements after June 27, 2023. New or renewed DEA registrants must have eight hours of training on treatment and management … Health Advisory: Buprenorphine and controlled substances prescribing
